Luca Fabris

20PUBLICATIONS
99CO-AUTHORS
Cancer diagnosisGene and molecular therapyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Dec 10, 2025
Cholangiocarcinoma 2026: status quo, unmet needs and priorities.

Jesus M Banales, Pedro M Rodrigues, Silvia Affò

|Sep 03, 2024
Liver-related aspects of valoctocogene roxaparvovec gene therapy for hemophilia A: expert guidance for clinical practice.

Vincenzo La Mura, Vincenzo Cardinale, Raimondo De Cristofaro

|Jan 23, 2024
Angiopoietin-2 and the Vascular Endothelial Growth Factor Promote Migration and Invasion in Hepatocellular Carcinoma- and Intrahepatic Cholangiocarcinoma-Derived Spheroids.

Adriana Romanzi, Fabiola Milosa, Gemma Marcelli

|Oct 31, 2023
FXR agonists INT-787 and OCA increase RECK and inhibit liver steatosis and inflammation in diet-induced ob/ob mouse model of NASH.

Laura G Di Pasqua, Marta Cagna, Giuseppina Palladini

|Sep 13, 2023
A TGFβ-ECM-integrin signaling axis drives structural reconfiguration of the bile duct to promote polycystic liver disease.

Scott H Waddell, Yuelin Yao, Paula Olaizola

|Mar 11, 2023
Intrahepatic Cholangiocarcinoma Developing in Patients with Metabolic Syndrome Is Characterized by Osteopontin Overexpression in the Tumor Stroma.

Massimiliano Cadamuro, Samantha Sarcognato, Riccardo Camerotto

Pageof 4

Frequent Collaborators

6 joint publications

Mario Strazzabosco

5 joint publications

Massimiliano Cadamuro

4 joint publications

Luke Boulter

4 joint publications

Jesus M Banales